Iterum Therapeutics ITRM

$ 1.87 5.65%

Quarterly report 2024-Q3
added 11-14-2024

Iterum Therapeutics Income Statement 2011-2024 | ITRM

Annual Income Statement Iterum Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	20 M	13.8 M	3.74 M	2.26 M	36.4 M	96.7 M	-	-	-	-	-	-	-
Shares	13 M	12.2 M	10.9 M	1.6 M	14.5 M	14.4 M	-	-	-	-	-	-	-
Historical Prices	1.54	1.13	0.343	1.41	2.32	6.14	-	-	-	-	-	-	-
Net Income	-38.4 M	-44.4 M	-91.6 M	-52 M	-103 M	-77.1 M	-29.4 M	-13.5 M	-	-	-	-	-
Revenue	-	-	-	-	37 K	869 K	508 K	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-47.5 M	-30.4 M	-24.5 M	-32.1 M	-102 M	-76.6 M	-29.5 M	-13.4 M	-	-	-	-	-
Interest Expense	82 K	503 K	195 K	213 K	196 K	401 K	216 K	8 K	-	-	-	-	-
EBITDA	-47.4 M	-30.3 M	-24.1 M	-32 M	-102 M	-76.4 M	-29.4 M	-13.4 M	-	-	-	-	-
Operating Expenses	47.5 M	30.4 M	24.5 M	32.1 M	102 M	77.4 M	-	-	-	-	-	-	-
General and Administrative Expenses	7.48 M	12.8 M	13.8 M	11.1 M	11.3 M	8.78 M	4.46 M	3.26 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Iterum Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	20 M	16.6 M	15.4 M	13 M	12.9 M	12.7 M	-	12.2 M	12.2 M	12.2 M	-	12.2 M	180 M	122 M	40.6 M	20.4 M	15.6 M	14.9 M	14.9 M	14.6 M	14.3 M	14.3 M	14.1 M	14 M	7.09 M	198 K	-	185 K	159 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-6.09 M	-5 M	-7.1 M	-3.88 M	-12.2 M	-9.89 M	-	-29.1 M	-6.74 M	-3.5 M	-	3.74 M	7.8 M	-98.9 M	-11.2 M	-52 M	-52 M	-52 M	-23.6 M	-103 M	-103 M	-103 M	-24.3 M	-77.1 M	-77.1 M	-77.1 M	-	-29.4 M	-29.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37 K	37 K	37 K	239 K	254 K	185 K	191 K	-	159 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-4.89 M	-3.98 M	-6.16 M	-16.7 M	-10.8 M	-8.53 M	-	-7.03 M	-8.05 M	-7.37 M	-	-4.87 M	-6.99 M	-5.85 M	-	-6.34 M	-8.25 M	-12.9 M	-	-31 M	-27.4 M	-20.5 M	-	-25 M	-15.4 M	-12.2 M	-	-8.3 M	-6.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-48 K	-12 K	-17 K	70 K	50 K	41 K	-	175 K	269 K	162 K	-	33 K	93 K	41 K	-	68 K	-3 K	-38 K	-	48 K	32 K	124 K	-	328 K	-177 K	61 K	-	90 K	165 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-6.16 M	-	-	-8.52 M	-	-6.96 M	-8 M	-7.34 M	-	-4.54 M	-6.77 M	-5.81 M	-	-6.17 M	-8.09 M	-12.7 M	-	-30.8 M	-27.2 M	-20.3 M	-	-24.8 M	-15.3 M	-12.1 M	-	-8.23 M	-6.35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	4.89 M	3.98 M	6.16 M	16.7 M	10.8 M	8.53 M	-	7.03 M	8.05 M	7.37 M	-	4.87 M	6.99 M	5.85 M	4.64 M	6.34 M	8.25 M	12.9 M	23.2 M	31 M	27.4 M	20.5 M	24.2 M	25.2 M	15.6 M	12.4 M	-	8.46 M	6.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.78 M	1.9 M	2.19 M	1.83 M	1.86 M	2.1 M	-	2.68 M	4.07 M	3.93 M	-	3.03 M	4.27 M	3.4 M	-	2.4 M	3.21 M	3.15 M	-	2.93 M	2.94 M	3.12 M	-	2.66 M	1.89 M	1.52 M	-	1.02 M	1.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency